Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Finkle, William D ^a   Greenland, Sander ^b   Ridgeway, Gregory K ^a   Adams, John L ^a   Frasco, Melissa A ^a   Cook, Michael B ^c   Fraumeni Jr , Joseph F ^c   Hoover, Robert N ^c  

^a Consolidated Research Inc ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SILDENAFIL; TADALAFIL; TESTOSTERONE; TESTOSTERONE CIPIONATE;

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; AGED; ANDROGEN DEFICIENCY; ANDROGEN THERAPY; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; GEL; HEART DISEASE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT;

AGE FACTORS; AGED; CARBOLINES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PHOSPHODIESTERASE 5 INHIBITORS; PIPERAZINES; PRESCRIPTION DRUGS; PURINES; RISK; SULFONES; TESTOSTERONE;

EID: 84899654297     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085805     Document Type: Article

References (32)

1. Page ST, Amory JK, Bowman FD, Anawalt BD, Matsumoto AM, et al. (2005) Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab 90: 1502-1510. (Pubitemid 40464011)
2. Baillargeon J, Urban RJ, Ottenbacher KJ, Pierson KS, Goodwin JS (2013) Trends in androgen prescribing in the United States, 2001 to 2011. JAMA Internal Medicine: 1-2.
3. O'Connor A (2013) Men's use of hormones on the rise. New York Times.
4. Basaria S, Coviello AD, Travison TG, Storer TW, Farwell WR, et al. (2010) Adverse Events Associated with Testosterone Administration. New England Journal of Medicine 363: 109-122.
5. Xu L, Freeman G, Cowling BJ, Schooling CM (2013) Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials. BMC Med 11: 108.
6. Vigen R, O'Donnell CI, Barón AE, Grunwald GK, Maddox TM, et al. (2013) ASsociation of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA 310: 1829-1836.
7. Bremner WJ (2010) Testosterone Deficiency and Replacement in Older Men. New England Journal of Medicine 363: 189-191.
8. Hensen LG, Chang S (2010) Health research data for the real world: The Thompson Reuters Marketscan Databases. White paper. Ann Arbor, MI.
9. Jackson G, Montorsi P, Cheitlin MD (2006) Cardiovascular safety of sildenafil citrate (Viagra): an updated perspective. Urology 68: 47-60. (Pubitemid 44441519)
10. Seeger JD, Walker AM, Williams PL, Saperia GM, Sacks FM (2003) A propensity score-matched cohort study of the effect of statins, mainly fluvastatin, on the occurrence of acute myocardial infarction. Am J Cardiol 92: 1447-1451. (Pubitemid 37532570)
11. Hirano K, Imbens G (2001) Estimation of Causal Effects using Propensity Score Weighting: An Application to Data on Right Heart Catheterization. Health Services and Outcomes Research Methodology 2: 259-278.
12. Bang H, Robins JM (2005) Doubly robust estimation in missing data and causal inference models. Biometrics 61: 962-973.
13. Rothman KJ, Greenland S, Lash TL (2008) Modern epidemiology. Philadelphia, Pa.; London: Lippincott Williams & Wilkins.
14. Roger VL, Weston SA, Killian JM, Pfeifer EA, Belau PG, et al. (2001) Time trends in the prevalence of atherosclerosis: a population-based autopsy study. Am J Med 110: 267-273. (Pubitemid 32187286)
15. Oliva A, Flores J, Merigioli S, LeDuc L, Benito B, et al. (2011) Autopsy investigation and Bayesian approach to coronary artery disease in victims of motor-vehicle accidents. Atherosclerosis 218: 28-32.
16. Corona G, Rastrelli G, Monami M, Guay A, Buvat J, et al. (2011) Hypogonadism as a risk factor for cardiovascular mortality in men: a metaanalytic study. Eur J Endocrinol 165: 687-701.
17. Ruige JB, Mahmoud AM, De Bacquer D, Kaufman JM (2011) Endogenous testosterone and cardiovascular disease in healthy men: a meta-analysis. Heart 97: 870-875.
18. Spitzer M, Huang G, Basaria S, Travison TG, Bhasin S (2013) Risks and benefits of testosterone therapy in older men. Nat Rev Endocrinol 9: 414-424.
19. Marchioli R, Finazzi G, Specchia G, Cacciola R, Cavazzina R, et al. (2013) Cardiovascular events and intensity of treatment in polycythemia vera. N Engl J Med 368: 22-33.
20. Fernandez-Balsells MM, Murad MH, Lane M, Lampropulos JF, Albuquerque F, et al. (2010) Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. J Clin Endocrinol Metab 95: 2560-2575.
21. Baskurt OK, Meiselman HJ (2012) Iatrogenic hyperviscosity and thrombosis. Semin Thromb Hemost 38: 854-864.
22. Ajayi AA, Mathur R, Halushka PV (1995) Testosterone increases human platelet thromboxane A2 receptor density and aggregation responses. Circulation 91: 2742-2747.
23. Peerschke EI, Silver RT, Weksler BB, Yin W, Bernhardt B, et al. (2007) Examination of platelet function in whole blood under dynamic flow conditions with the cone and plate(let) analyzer: effect of erythrocytosis and thrombocytosis. Am J Clin Pathol 127: 422-428. (Pubitemid 46806336)
24. Swerdloff RS, Wang C, Cunningham G, Dobs A, Iranmanesh A, et al. (2000) Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. J Clin Endocrinol Metab 85: 4500-4510. (Pubitemid 32157624)
25. Urhausen A, Torsten A, Wilfried K (2003) Reversibility of the effects on blood cells, lipids, liver function and hormones in former anabolic-androgenic steroid abusers. J Steroid Biochem Mol Biol 84: 369-375. (Pubitemid 36514853)
26. JAMA (1970) The Coronary Drug Project. Initial findings leading to modifications of its research protocol. JAMA 214: 1303-1313.
27. Hulley S, Grady D, Bush T, Furberg C, Herrington D, et al. (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 280: 605-613. (Pubitemid 28502636)
28. Lidegaard O, Lokkegaard E, Jensen A, Skovlund CW, Keiding N (2012) Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med 366: 2257-2266.
29. Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, et al. (2007) Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 297: 1465-1477. (Pubitemid 46556472)
30. Sandset PM, Hoibraaten E, Eilertsen AL, Dahm A (2009) Mechanisms of thrombosis related to hormone therapy. Thromb Res 123 Suppl 2: S70-73.
31. Petersen LA, Wright S, Normand SL, Daley J (1999) Positive predictive value of the diagnosis of acute myocardial infarction in an administrative database. J Gen Intern Med 14: 555-558. (Pubitemid 29441635)
32. Greenland P, Knoll MD, Stamler J, Neaton JD, Dyer AR, et al. (2003) Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA 290: 891-897. (Pubitemid 37430460)